Immune system works on battling against the foreign invaders. However cancer cells not being outside cells to the host are exceptionally hard to be recognized by the host immunity as risk. Just when the cancer cells begin to discharge certain molecules which are particular to the cancer cells, host immune cells attempt to act against the cancer cells.
Cancer immunosurveillance is viewed as the main dependable host mechanism against the tumour development in the human body by repressing the carcinogenesis and furthermore keeping up a normal cell homeostasis.
- Track 1-1 Tumour Immunology
- Track 2-2 Dendritic cell therapy and CAR-T cell therapy
- Track 3-3 Polysaccharide-K
- Track 4-4 Cytokine therapy
- Track 5-5 FDA-approved antibodies
- Track 6-6 Immune checkpoint inhibitors
- Track 7-7 Immuno-Oncology studies